Mecasermin

Names

[ Name ]:
Mecasermin

Biological Activity

[Description]:

Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies[1].

[Related Catalog]:

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> IGF-1R

Research Areas >> Metabolic Disease

[In Vivo]

Mecasermin (rhIGF1; 0.25 mg/kg; i.p.; daily; 6 weeks) 可将血清中的 IGF1 浓度提高至接近正常水平，并改善多种表型，包括机体和行为功能、突触和回路可塑性、神经元结构和分子信号通路[2]。 Animal Model: Mecp2 hemizygous KO mice[2] Dosage: 0.25 mg/kg Administration: i.p.; daily; 6 weeks Result: Improved lifespan, locomotor activity, heart rate, respiration patterns, and social and anxiety behavior.

[References]

[1]. Arlan L Rosenbloom. Mecasermin (recombinant human insulin-like growth factor I). Adv Ther. 2009 Jan;26(1):40-54.

[2]. Jorge Castro, et al. Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9941-6.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.